anti-L1CAM antibody radionuclide conjugate (CIS Pharma AG/Paul Scherrer Institut/KU Leuven)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2025/06/11 11:07:03

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐanti-L1CAM antibody radionuclide conjugate (CIS Pharma AG/Paul Scherrer Institut/KU Leuven)
่ฏ็‰ฉๅˆซ็งฐN/A
่ฏ็‰ฉ็ฑปๅž‹็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๆŠ—ไฝ“็ผ€ๅˆ็‰ฉ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“็ผ€ๅˆ็‰ฉ็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“็ผ€ๅˆ็‰ฉ็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ไบบๆบๅŒ–ๅ•ๅ…‹้š†ๆŠ—ไฝ“
ไฝœ็”จๆœบๅˆถ็ฅž็ป็ป†่ƒž็ฒ˜้™„ๅˆ†ๅญL1ๆŠ‘ๅˆถๅ‰‚
้ถ็‚น็ฅž็ป็ป†่ƒž็ฒ˜้™„ๅˆ†ๅญL1
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡ๅตๅทข็™Œ
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸๆฏ”ๅˆฉๆ—ถ็‘žๅฃซ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ไธดๅบŠๅ‰
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธPaul Scherrer Institut
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธCIS Pharma AGPaul Scherrer InstitutKu Leuven
้žๆดป่ทƒๅ…ฌๅธN/A
ๆดป่ทƒ้€‚ๅบ”็—‡ๅตๅทข็™Œ
้žๆดป่ทƒ้€‚ๅบ”็—‡N/A

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A